National Institute on Drug Abuse; Notice of Closed Meeting, 7571-7572 [2011-2988]
Download as PDF
<![CDATA[
7571
Federal Register / Vol. 76, No. 28 / Thursday, February 10, 2011 / Notices
Infertility Research LRP (CIR–LRP) is
authorized by section 487B of the PHS
Act (42 U.S.C. 288–2), and the Health
Disparities Research LRP (HD–LRP) is
authorized by section 485G (42 U.S.C.
287c–33).
The Loan Repayment Programs can
repay up to $35,000 per year toward a
participant’s extant eligible educational
loans, directly to financial institutions.
The information proposed for collection
will be used by the Division of Loan
Repayment to determine an applicant’s
eligibility for participation in the
program. Frequency of Response: Initial
application and one- or two-year
Estimated
number of
responses per
respondent
Number of
respondents
Type of respondents
renewal application. Affected Public:
Individuals or households, nonprofits,
and businesses or other for-profit. Type
of Respondents: Physicians, other
scientific or medical personnel, and
institutional representatives. The annual
reporting burden is as follows:
Average
burden hours
per response
Annual burden
hours requested
50
50
140
10
1
1
1
1
10.11
1
.5
.25
505.50
50.00
70.00
2.50
Subtotal .............................................................................
250
............................
............................
628.00
Extramural LRPs:
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
Financial Institutions .................................................................
2,050
1,840
6,150
100
1
1
1
1
10.75
1
.5
.25
22,037.50
1,840.00
3,075.00
25.00
Subtotal .............................................................................
10,140
............................
............................
26,977.50
Intramural LRPs:
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
50
50
1
1
7.42
2.2
371.00
110.00
Subtotal .............................................................................
100
............................
............................
481.00
Extramural LRPS:
Renewal Applicants ..................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
1,200
900
3,500
1
1
1
8.58
1.7
.5
10,296.00
1,530.00
1,750.00
Subtotal .............................................................................
5,600
............................
............................
13,576.00
Total ...........................................................................
jdjones on DSK8KYBLC1PROD with NOTICES
Intramural LRPs:
Initial Applicants ........................................................................
Advisors/Supervisors ................................................................
Recommenders ........................................................................
Financial Institutions .................................................................
16,090
............................
............................
41,662.50
The annualized cost to respondents is
estimated at $1,701,641.69. The
annualized cost to the Federal
Government for administering the Loan
Repayment Programs is expected to be
$1,448,100. This cost includes
administrative support by the Division
of Loan Repayment and $800,000 for the
continuing development and
maintenance of the LRP Management
Information System/Online Application
System (MIS/OAS).
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
VerDate Mar<15>2010
15:10 Feb 09, 2011
Jkt 223001
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Milton Hernandez,
PhD, Director, Division of Loan
Repayment, National Institutes of
Health, 6011 Executive Blvd., Room 206
(MSC 7650), Bethesda, Maryland
20892–7650. Dr. Hernandez may be
contacted via e-mail at mh35c.@nih.gov
or by calling 301–496–0180.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Dated: February 4, 2011.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2011–2995 Filed 2–9–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
E:\FR\FM\10FEN1.SGM
10FEN1
7572
Federal Register / Vol. 76, No. 28 / Thursday, February 10, 2011 / Notices
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Multiplexed Sensitive Testing for Drugs of
Abuse (2220).
Date: February 15, 2011.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 4, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–2988 Filed 2–9–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jdjones on DSK8KYBLC1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vascular Biology.
Date: February 16–17, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
15:10 Feb 09, 2011
Jkt 223001
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Larry Pinkus, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical and Integrative
Cardiovascular Sciences.
Date: February 16, 2011.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Olga A. Tjurmina, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 451–
1375, ot3d@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Biology of
Host Response to Oral Microbial Infections.
Date: February 17, 2011.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Yi-Hsin Liu, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4214,
MSC 7814, Bethesda, MD 20892, 301–435–
1781, liuyh@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 4, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–2998 Filed 2–9–11; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Interagency Breast Cancer and
Environmental Research Coordinating
Committee Research Translation,
Dissemination, and Policy Implications
Subcommittee.
These meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance or
reasonable accommodations, should
inform the Contact Person listed below
at least 10 days in advance of the
meeting.
Name of Committee: Interagency Breast
Cancer and Environmental Research
Coordinating Committee (IBCERC) Research
Translation, Dissemination, and Policy
Implications Subcommittee.
Date: March 18, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: The purpose of the meeting is to
continue the work of the Research
Translation, Dissemination, and Policy
Implications Subcommittee as it addresses a
broad set of objectives related to the overall
mandate of the IBCERC including: increasing
public participation in decisions relating to
breast cancer research by increasing the
involvement of patient advocacy and
community organizations representing a
broad geographical area and creating models
for dissemination of information regarding
the progress of breast cancer research. The
meeting agenda will be available on the Web
at https://www.niehs.nih.gov/about/
orgstructure/boards/ibcercc/.
Place: Conference Call: This meeting will
be conducted remotely, via conference call.
To attend the meeting, please RSVP via email to ibcercc@niehs.nih.gov at least 10 days
in advance and instructions for joining the
meeting will be provided.
Contact Person: Gwen W. Collman, PhD,
Director, Division of Extramural Research
and Training, National Institute of
Environmental Health Sciences, 615 Davis
Dr., KEY615/3112, Research Triangle Park,
NC 27709, (919) 541–4980,
collman@niehs.nih.gov.
Name of Committee: Interagency Breast
Cancer and Environmental Research
Coordinating Committee (IBCERC) Research
Translation, Dissemination, and Policy
Implications Subcommittee.
Date: April 15, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: The purpose of the meeting is to
continue the work of the Research
Translation, Dissemination, and Policy
Implications Subcommittee as it addresses a
broad set of objectives related to the overall
mandate of the IBCERC including: increasing
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 76, Number 28 (Thursday, February 10, 2011)]
[Notices]
[Pages 7571-7572]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2988]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
USC, as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials,
[[Page 7572]]
and personal information concerning individuals associated with the
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Multiplexed Sensitive Testing for Drugs of Abuse
(2220).
Date: February 15, 2011.
Time: 1:30 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1439, lf33c.@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: February 4, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-2988 Filed 2-9-11; 8:45 am]
BILLING CODE 4140-01-P
